| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Operations | Senior VP, Clinical Operations | Chief Medical Officer
1 company
Alcorn Harry W Jr is a SVP, Clinical Operations at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $255K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | DMAC Diamedica Therapeutics Inc. | SVP, Clinical Operations | Buy | 15,000 | $3.80 | $56,959.50 | +52.5% | -2.8% | -62.5% | |
| Aug 16, 2021 | DMAC Diamedica Therapeutics Inc. | Senior VP, Clinical Operations | Buy | 20,721 | $3.09 | $64,053.86 | +56.7% | +22.5% | -44.1% | |
| Aug 16, 2019 | DMAC Diamedica Therapeutics Inc. | Chief Medical Officer | Buy | 7,260 | $2.67 | $19,365.32 | +726.0% | - | - | |
| Mar 27, 2019 | DMAC Diamedica Therapeutics Inc. | Chief Medical Officer | Buy | 150 | $4.46 | $668.39 | +15.0% | - | - | |
| Dec 11, 2018 | DMAC Diamedica Therapeutics Inc. | Chief Medical Officer | Buy | 1,000 | $4.00 | $4,000.00 | New | - | - |